On the other hand, L-MDS, a disease stage progressing towards AML with additional genetic lesions, is characterized by increased numbers of Tregs [28], dysfunctional NK cells [29] and higher immunoinhibitory molecule B7-H1 expression on MDS blasts [22], resulting in immune evasion of the malignant clone. The gene discussed is CD274; the disease is myelodysplastic syndrome.